Literature DB >> 1704066

Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds.

M Cushman1, S Kanamathareddy, E De Clercq, D Schols, M E Goldman, J A Bowen.   

Abstract

Several compounds corresponding to fragments of the schematic representation of the polymeric structure of aurintricarboxylic acid (ATA) have been prepared and tested for prevention of the cytopathic effect of HIV-1 and HIV-2 in MT-4 cell culture and HIV-1 in CEM cell culture. Both the triphenylcarbinol 3 as well as the triphenylmethane 5 were found to afford protection against the cytopathogenicity of HIV-2 in MT-4 cells and HIV-1 in CEM cells, but they were inactive against HIV-1 in MT-4 cells. Both substances were also found to inhibit syncytium formation when MOLT-4 cells were cocultured with HIV-2-infected HUT-78 cells, but were inactive in this assay against HIV-1-infected cells. When observed, the activity is generally moderate in degree of protection and requires concentrations in the 10(-4) molar range. In contrast to ATA, both of these substances were inactive when tested for prevention of the binding of the OKT4A monoclonal antibody to the CD4 receptor and also for inhibition of HIV-1 reverse transcriptase. These substances therefore appear act by a mechanism that is distinct from that of polymeric ATA. Several active and inactive structural analogues of 3 and 5 were also synthesized. The anti-HIV activity in this series seems to depend on the presence of anionic carboxylate groups, since the methyl esters 4, 6, and 12 were uniformly inactive. The diphenylmethanes 8, 14, 18, and 19 also reproducibly inhibited the cytopathic effect of HIV-1 in CEM cell culture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704066     DOI: 10.1021/jm00105a053

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.

Authors:  Pallavi Rajaputra; Moses Bio; Gregory Nkepang; Pritam Thapa; Sukyung Woo; Youngjae You
Journal:  Bioorg Med Chem       Date:  2016-02-21       Impact factor: 3.641

2.  Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.

Authors:  S Rusconi; M Moonis; D P Merrill; P V Pallai; E A Neidhardt; S K Singh; K J Willis; M S Osburne; A T Profy; J C Jenson; M S Hirsch
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

3.  Characterization of Aurintricarboxylic Acid (ATA) Interactions with Plasma Transporter Protein and SARS-CoV-2 Viral Targets: Correlation of Functional Activity and Binding Energetics.

Authors:  Conceição A Minetti; David P Remeta; Keiji Hashimoto; Radha Bonala; Rajesh Chennamshetti; Xingyu Yin; Miguel Garcia-Diaz; Arthur P Grollman; Francis Johnson; Viktoriya S Sidorenko
Journal:  Life (Basel)       Date:  2022-06-10

4.  Inhibition of human immunodeficiency virus integrase by bis-catechols.

Authors:  R L LaFemina; P L Graham; K LeGrow; J C Hastings; A Wolfe; S D Young; E A Emini; D J Hazuda
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

5.  Synthesis of triarylmethanols via tandem arylation/oxidation of diarylmethanes.

Authors:  Jianyou Mao; Kelly Eberle; Jiadi Zhang; Carles Rodriguez; Zhenfeng Xi; Miquel A Pericàs; Patrick J Walsh
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

Review 6.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

Review 7.  Potential antivirals and antiviral strategies against SARS coronavirus infections.

Authors:  Erik De Clercq
Journal:  Expert Rev Anti Infect Ther       Date:  2006-04       Impact factor: 5.091

8.  Copper-mediated arylation with arylboronic acids: Facile and modular synthesis of triarylmethanes.

Authors:  H Surya Prakash Rao; A Veera Bhadra Rao
Journal:  Beilstein J Org Chem       Date:  2016-03-11       Impact factor: 2.883

9.  In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.

Authors:  Pavel Klein; Oscar Cirioni; Andrea Giacometti; Giorgio Scalise
Journal:  J Antimicrob Chemother       Date:  2008-07-23       Impact factor: 5.790

10.  Aurintricarboxylic acid inhibits influenza virus neuraminidase.

Authors:  Hui-Chen Hung; Ching-Ping Tseng; Jinn-Moon Yang; Yi-Wei Ju; Sung-Nain Tseng; Yen-Fu Chen; Yu-Sheng Chao; Hsing-Pang Hsieh; Shin-Ru Shih; John T-A Hsu
Journal:  Antiviral Res       Date:  2008-11-17       Impact factor: 5.970

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.